✦ LIBER ✦

Mu opiate isoreceptors: Differentiation with kappa agonists

✍ Scribed by P.L. Wood; J.W. Richard; M. Thakur

Book ID: 118940928
Publisher: Elsevier Science
Year: 1982
Tongue: English
Weight: 207 KB
Volume: 31
Category: Article
ISSN: 0024-3205
DOI: 10.1016/0024-3205(82)90145-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Different types of opiate agonists inter

Different types of opiate agonists interact distinguishably with mu, delta and kappa opiate binding sites

✍ Andreas Pfeiffer; Albert Herz 📂 Article 📅 1982 🏛 Elsevier Science 🌐 English ⚖ 243 KB

Mu and kappa opiate receptor involvement

Mu and kappa opiate receptor involvement in agonistic behaviour in mice

✍ David Benton 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 561 KB

Phencyclidine-induced inhibition of stri

Phencyclidine-induced inhibition of striatal acetylcholine release: Comparisons with mu, kappa, and sigma opiate agonists

✍ Steven M. Leventer; Kenneth M. Johnson 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 484 KB

Mu- and kappa-opiate agonists modulate i

Mu- and kappa-opiate agonists modulate ingestive behaviors in the slug, Limax maximus

✍ M. Kavaliers; R.W. Rangeley; M. Hirst; G.C. Teskey 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 528 KB

Orally administered kappa as well as mu

Orally administered kappa as well as mu opiate agonists delay gastrointestinal transit time in the guinea pig

✍ J. Culpepper-Morgan; M.J. Kreek; P.R. Holt; D. LaRoche; J. Zhang; L. O'Bryan 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 362 KB

Differential effect of mu, delta, and ka

Differential effect of mu, delta, and kappa opioid agonists on adenylate cyclase activity

✍ Dr. G. M. de Montis; P. Devoto; A. Preti; A. Tagliamonte 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 403 KB

D-Ala2, D-Leu5-enkephalin (DADLE) and dynorphinl -13 (Dynl -13) inhibited striatal adenylate cyclase activity, both basal and dopamine-stimulated (DA), in rats and guinea pigs. The K-agonists bremazocine (BRZ), U-50,488 (trans-3,4-dicloro-N-methyl-N-[2-(1-pyrrolidiny1)-cyclohexyl]-benzeneacetamide),